Researcher
Bieke Decaesteker
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Biomolecular Medicine (Department)
Member
From1 Oct 2018 → 2 Jan 2023 - Department of Pediatrics and medical genetics (Department)
Member
From1 Sep 2013 → 30 Sep 2018
Publications
21 - 30 of 48
- The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2018)
Authors: Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Fanny De Vloed, Moritz Gartlgruber, Pauline Depuydt, Wouter Van Loocke, Shana Claeys, Dries Rombaut, Anton Henssen, et al.
Number of pages: 1 - In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors(2018)
Authors: Suzanne Vanhauwaert, Bieke Decaesteker, Sara De Brouwer, Carina Leonelli, Pieter Mestdagh, Karen Sermon, Geertrui Denecker, Christophe Van Neste
- The core regulatory circuit component TBX2 is implicated in cell cycle control and proliferation in neuroblastoma(2017)
Authors: Bieke Decaesteker, Geertrui Denecker, Wouter Van Loocke, Moritz Gartlgruber, Pauline Depuydt, Fanny De Vloed, Shana Claeys, Dries Rombaut, Anton Henssen, Daniel Dreidax, et al.
Number of pages: 1 - RRM2 is an essential and druggable component of the FOXM1 driven replicative stress DNA damage response in neuroblastoma(2017)
Authors: Pauline Depuydt, Suzanne Vanhauwaert, Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste
Number of pages: 1 - RRM2 is an essential and druggable component of the FOXM1 driven replicative stress DNA damage response in neuroblastoma(2017)
Authors: Pauline Depuydt, Suzanne Vanhauwaert, Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste
Number of pages: 1 - The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex(2017)
Authors: Shana Claeys, Geertrui Denecker, Bieke Decaesteker, Candy Kumps, Sara De Brouwer, Irina Lambertz, Annelies Fieuw, Suzanne Vanhauwaert, Kristina Althoff, Laurel Bate-Eya, et al.
Number of pages: 1 - The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complexVolume: 58
Authors: Geertrui Denecker, Shana Claeys, Irina Lambertz, Suzanne Vanhauwaert, Bieke Decaesteker, Kristina Althoff, Johannes Schulte, Jean-Baptiste Demoulin, Stephen S Roberts, Laurel Bate-Eya, et al.
Pages: 1484 - 1484 - The chromosome 17q super-enhancer landscape in neuroblastoma
Authors: Bieke Decaesteker, Anton Henssen, Wouter Van Loocke, Francisco Avila Cobos, Anneleen Beckers, Stein Aerts, Johannes Schulte
Number of pages: 1 - Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN
Authors: Chi Yan Ooi, Daniel R Carter, Bing Liu, Chelsea Mayoh, Anneleen Beckers, Amit Lalwani, Zsuzsanna Nagy, Sara De Brouwer, Bieke Decaesteker, Tzong-Tyng Hung, et al.
Pages: 3122 - 3034 - The chromosome 17q super-enhancer landscape in neuroblastoma
Authors: Bieke Decaesteker, Anton Henssen, Wouter Van Loocke, Anneleen Beckers, Stein Aerts, Johannes Schulte
Pages: 39 - 39